Physician profile
David Field
NPI 1598788390
$4,617.60
in general payments reported to CMS, 2019-2025
41 companies · $67.15 in 2025
The $67.15 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,215 · 2020: $276 · 2021: $63.42 · 2022: $710 · 2023: $926 · 2024: $359 · 2025: $67.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $388.91 | 2022-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $380.07 | 2019-2023 | Farxiga |
| Astellas Pharma US INC | $328.69 | 2019-2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.55 | 2019-2023 | Jardiance, Tradjenta |
| Lilly USA, LLC | $304.80 | 2019-2024 | Mounjaro, Jardiance |
| Pfizer INC. | $294.50 | 2019-2024 | |
| Novo Nordisk INC | $290.41 | 2019-2023 | Rybelsus, Ozempic |
| Amgen INC. | $285.34 | 2019-2023 | Prolia, Evenity |
| Novartis Pharmaceuticals Corporation | $247.57 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $165.28 | 2019-2020 | |
| Abbott Laboratories | $150.23 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $142.22 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $118.43 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $110.20 | 2019-2023 | Ultomiris |
| Allergan, INC. | $100.37 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.